Oregon House Passes Bill to End Hard Drug Decriminalization

There are many factors in setting drug policy, which often center around the benefits or detriments to a society and its economy.

Seeking AlphaMar 1 06:42 ET

Mydecine Innovations Closes Partial Debt Settlement

Mydecine Innovations Group (0NF0.F) completed a partial settlement for its outstanding debts to an unnamed creditor, according to a Friday filing. The biotechnology company settled a $52,370.86 debt b

MT NewswiresFeb 23 05:32 ET

Psychedelic Stocks Gain After FDA Priority Review for MDMA Therapy

Seeking AlphaFeb 12 12:13 ET

Mydecine Innovations Group Receives Notice of Allowance From USPTO For MYCO-005 Compound

Mydecine Innovations Group, Inc., (MYCO.CSE) on Monday said it has received the issuance of a Notice of Allowance by the United States Patent and Trademark Office (USPTO) for their MYCO-005 compound.

MT NewswiresDec 18, 2023 07:23 ET

Mydecine Innovations Group Provided Q4 2023 Business Update

Mydecine Innovations Group, Inc., (MYCO.CSE) earlier Thursday provided a general update. The company has spent the past few months simplifying its business model, streamline workflow and processes, an

MT NewswiresOct 26, 2023 07:48 ET

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE:CYBN) and UK-based Small Pharma Inc. (OTC:DMTTF) held their re

BenzingaOct 16, 2023 15:57 ET